Evidence-based treatment of anxiety disorders (Q38220450)

31 August 2017

title

Evidence-based treatment of anxiety disorders (English)

1 reference

31 August 2017

1

1 reference

31 August 2017

publication date

1 January 2006

1 reference

International Journal of Psychiatry in Clinical Practice

31 August 2017

published in

1 reference

31 August 2017

volume

10 Suppl 1

1 reference

31 August 2017

page(s)

16-21

1 reference

Evidence based medicine: what it is and what it isn't

31 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1080%2F13651500600552487

Evidence-based medicine. A new approach to teaching the practice of medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13651500600552487

Clinical psychopharmacologic practice. The need for developing a research base.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13651500600552487

Guidelines for clinical guidelines

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13651500600552487

Flawed Meta-Analyses Comparing Psychotherapy With Pharmacotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13651500600552487

Practice parameters for the assessment and treatment of children and adolescents with anxiety disorders. American Academy of Child and Adolescent Psychiatry

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13651500600552487

World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Pharmacological Treatment of Anxiety, Obsessive-Compulsive and Posttraumatic Stress Disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13651500600552487

The efficacy of antidepressants for generalized anxiety disorder: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13651500600552487

Cognitive behavioral and pharmacological treatment of generalized anxiety disorder: A preliminary meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13651500600552487

Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13651500600552487

Revised prevalence estimates of mental disorders in the United States: using a clinical significance criterion to reconcile 2 surveys' estimates

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13651500600552487

Social anxiety disorder : current treatment recommendations

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13651500600552487

Pharmacological treatment of social anxiety disorder: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13651500600552487

Prevention of relapse in generalized social phobia: results of a 24-week study in responders to 20 weeks of sertraline treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13651500600552487

Sertraline treatment of generalized social phobia: a 20-week, double-blind, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13651500600552487

An evaluation of paroxetine in generalised social anxiety disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13651500600552487

Escitalopram versus citalopram: the surprising role of the R-enantiomer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13651500600552487

Efficacy and tolerability of escitalopram in 12- and 24-week treatment of social anxiety disorder: randomised, double-blind, placebo-controlled, fixed-dose study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13651500600552487

Discontinuation of clonazepam in the treatment of social phobia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13651500600552487

Social phobia: diagnosis and epidemiology, neurobiology and pharmacology, comorbidity and treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13651500600552487

Antidepressants for generalised anxiety disorder (GAD)

21 January 2018

1 reference

30 December 2023

https://opencitations.net/index/api/v1/citations/10.1002/14651858.CD003592

Identifiers

DOI

10.1080/13651500600552487

1 reference

31 August 2017

1 reference